Showing results (1331-1340 of 5,989) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|November 1, 2012
Simultaneous targeting of COX-2 and AKT using selenocoxib-1-GSH to inhibit melanomaRaghavendra Gowda, Subbarao V Madhunapantula, Dhimant Desai, et al.
Molecular Cancer Therapeutics|February 20, 2015
A novel neutralizing antibody targeting pregnancy-associated plasma protein-a inhibits ovarian cancer growth and ascites accumulation in patient mouse tumorgraftsMarc A Becker, Paul Haluska, Laurie K Bale, et al.
Molecular Cancer Therapeutics|February 20, 2015
Biomarker signatures correlate with clinical outcome in refractory metastatic colorectal cancer patients receiving bevacizumab and everolimusYingmiao Liu, Mark D Starr, John C Brady, et al.
Molecular Cancer Therapeutics|February 22, 2015
Trifluridine Induces p53-Dependent Sustained G2 Phase Arrest with Its Massive Misincorporation into DNA and Few DNA Strand BreaksKazuaki Matsuoka, Makoto Iimori, Shinichiro Niimi, et al.
Molecular Cancer Therapeutics|March 1, 2015
βIII-Tubulin Regulates Breast Cancer Metastases to the BrainDeepak Kanojia, Ramin A Morshed, Lingjiao Zhang, et al.
Molecular Cancer Therapeutics|March 1, 2015
Frequent Loss of NISCH Promotes Tumor Proliferation and Invasion in Ovarian Cancer via Inhibiting the FAK Signal PathwayJing Li, Xiaoying He, Ruofan Dong, et al.
Molecular Cancer Therapeutics|April 5, 2015
CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab VedotinRobert Chen, Jessie Hou, Edward Newman, et al.
Molecular Cancer Therapeutics|April 9, 2015
On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 PatientsMaria Schwaederle, Gregory A Daniels, David E Piccioni, et al.
Molecular Cancer Therapeutics|April 9, 2015
Recruitment of Oligoclonal Viral-Specific T cells to Kill Human Tumor Cells Using Single-Chain Antibody-Peptide-HLA Fusion MoleculesRoy Noy, Maya Haus-Cohen, Kfir Oved, et al.
Molecular Cancer Therapeutics|April 9, 2015
Selective Delivery of PEGylated Compounds to Tumor Cells by Anti-PEG Hybrid AntibodiesHsin-Yi Tung, Yu-Cheng Su, Bing-Mae Chen, et al.
Pageof 599